RTW INVESTMENTS, LP's Net Worth
$0
Who is RTW INVESTMENTS, LP?
RTW INVESTMENTS, LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Prometheus Biosciences, Inc., Milestone Pharmaceuticals Inc., Tarsus Pharmaceuticals, Inc., Stoke Therapeutics, Inc., Athira Pharma, Inc., DermTech, Inc., ROCKET PHARMACEUTICALS, INC., Avidity Biosciences, Inc., Renovacor, Inc., Landos Biopharma, Inc., TELA Bio, Inc., Orchestra BioMed Holdings, Inc., and CARGO Therapeutics, Inc..
SEC CIK
RTW INVESTMENTS, LP's CIK is 0001493215
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Prometheus Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.26M |
$19.00 |
—
| 3.26M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Milestone Pharmaceuticals Inc. (MIST) Snapshot price: $1.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -24.54% | -1.06M |
—
|
—
| 3.26M |
Mar 22
| |||
Form 4
|
—
|
0
|
$8.71 |
—
| 8.63M |
Sep 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 22
| |||
Form 4
| +0.20% | 8.57K |
$10.71 | $91,832.63 | 4.32M |
Mar 18 - Mar 19
| |||
Form 4
| +1.85% | 78.26K |
$18.95 | $1,483,083.85 | 4.31M |
Mar 2
| |||
Form 4
| +6.82% | 270K |
$16.25 | $4,387,500.00 | 4.23M |
Jan 13
| |||
Form 4
| +0.58% | 22.77K |
$15.50 | $352,978.22 | 3.96M |
Dec 30 - Dec 31
| |||
Form 4
| +11.31% | 400K |
$16.00 | $6,400,000.00 | 3.94M |
Nov 20
| |||
Form 4
| +0.16% | 5.49K |
$17.40 | $95,454.83 | 3.54M |
Oct 10 - Oct 15
| |||
Form 4
| +0.23% | 8.15K |
$17.79 | $144,978.84 | 3.53M |
Oct 1 - Oct 3
| |||
Form 4
|
∞
| 3.52M |
$15.00 |
—
| 3.52M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tarsus Pharmaceuticals, Inc. (TARS) Snapshot price: $30.59
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -18.27% | -450.00K |
$29.98 | -$13,491,000.00 | 2.01M |
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.46% | -16.43K |
$28.70 | -$471,631.15 | 3.54M |
Nov 8
| |||
Form 4
| +3.03% | 104.87K |
$29.24 | $3,066,843.09 | 3.56M |
Nov 4
| |||
Form 4
| +2.03% | 68.78K |
$28.59 | $1,966,612.94 | 3.46M |
Oct 30 - Nov 1
| |||
Form 4
| +0.94% | 31.56K |
$21.96 | $693,029.20 | 3.39M |
Oct 1
| |||
Form 4
|
∞
| 3.36M |
$18.00 |
—
| 3.36M |
Jun 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Athira Pharma, Inc. (ATHA) Snapshot price: $0.5407
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +595.42% | 2.29M |
$17.00 |
—
| 2.67M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||